首页> 外国专利> Method for sensitizing bovine mammary cells to respond to LPS

Method for sensitizing bovine mammary cells to respond to LPS

机译:使牛乳腺细胞对LPS敏感的方法

摘要

Studies in mice and humans indicate that membrane CD14 (mCD14) on the cell surface of monocytes, macrophages, and PMN mediates the activation of these cells by LPS. The soluble CD14 (sCD14) present in the circulation also binds to LPS and blocks LPS binding to mCD14. To determine the role of a recombinant bovine soluble CD14 polypeptide in cellular activation by LPS, a recombinant bovine soluble CD14 polypeptide, rbosCD14, was cloned and expressed in a baculovirus expression system. Results indicated that rbosCD14 inhibited the LPS-induced increase in CD18 expression and TNFα mRNA in vitro and reduced mortality in mice injected with LPS. Further, rbosCD14 sensitized mammary epithelial cells to low concentrations of LPS resulting in recruitment of white blood cells and prevention of LPS-induced infection.
机译:在小鼠和人类中的研究表明,单核细胞,巨噬细胞和PMN的细胞表面上的膜CD14(mCD14)通过LPS介导了这些细胞的激活。存在于循环中的可溶性CD14(sCD14)也与LPS结合并阻止LPS与mCD14结合。为了确定重组牛可溶CD14多肽在LPS激活的细胞中的作用,克隆了重组牛可溶CD14多肽rbosCD14,并在杆状病毒表达系统中表达。结果表明,rbosCD14在体外抑制LPS诱导的CD18表达和TNFαmRNA的增加,并降低注射LPS的小鼠的死亡率。此外,rbosCD14使乳腺上皮细胞对低浓度的LPS敏感,从而导致白细胞募集并预防LPS诱导的感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号